Tecon

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Tecon

Property Description
Active ingredient Piroxicam
Form Capsule, Tablet, Injection, Gel
Pharmacological class Nonsteroidal Anti-inflammatory Drug (NSAID)
Common use Symptomatic relief of pain and inflammation
Origin Synthetic compound

What Type of Medicine is Tecon (Piroxicam)?

Tecon is a prescription-only synthetic medicinal preparation that contains the active substance Piroxicam and belongs to the therapeutic class of Nonsteroidal Anti-inflammatory Drugs (NSAIDs). Its anti-inflammatory and analgesic effects are clinically recognized and supported by pharmacological studies, which confirms its utility across various pain and swelling conditions. Piroxicam is specifically a member of the oxicam chemical group, an acidic structure that distinguishes it chemically from other common NSAID classes. Notably, the molecule exhibits an exceptionally long half-life in the body, which is a differentiating feature resulting in sustained plasma concentrations that require less frequent dosing compared to conventional, shorter-acting anti-inflammatory agents.


Composition, Forms, and General Therapeutic Purpose

The composition of Tecon focuses on the single active ingredient Piroxicam, which is formulated with appropriate pharmaceutical excipients for multiple administration routes to suit different therapeutic needs. The product is available as capsules and tablets for oral use, a solution prepared for intramuscular (IM) injection, and a gel designed for topical application. As a potent, non-selective inhibitor of cyclooxygenase (COX) enzymes, the medicine successfully reduces the production of prostaglandins, the chemical mediators central to pain signaling and inflammation. The general purpose of Tecon is to deliver effective symptomatic relief by suppressing the underlying inflammatory process, thereby reducing associated pain and swelling to improve daily function and comfort.

Regulatory References

  1. Piroxicam - LiverTox

What side effects are possible with Tecon?

Possible Side Effects and Safety Information for Tecon

Note: Authoritative government regulatory sources (such as the FDA, EMA, or NIH) do not currently list a prescription medicine with the name Tecon. The following structure reflects the required safety domains and organizational framework used by regulatory bodies for all approved medicinal products.

Documented Adverse Reactions

Category Regulatory Standard Status for Tecon
Frequency-Classified Reactions Side effects categorized as Very Common, Common, Uncommon, Rare, or Very Rare. Information Not Available
System-Organ Class (SOC) Grouping Adverse events grouped by the body system affected (e.g., Gastrointestinal, Nervous System, Immune System). Information Not Available
Serious Adverse Reactions Events resulting in severe outcomes like hospitalization, disability, or death, which are specifically highlighted in official labeling. Information Not Available

Safety Considerations and Restrictions

Domain Regulatory Standard Status for Tecon
Population-Specific Safety Documented risks and contraindications specific to subpopulations (e.g., pregnant patients, pediatric use, severe organ impairment). Information Not Available
Safety Restrictions and Limitations Formal statements defining specific patient conditions, co-medications, or monitoring requirements where the drug is restricted or contraindicated. Information Not Available

Regulatory Safety Profile Summary

The official safety structure for an approved medicine is based on a systematic assessment of risk, organizing all documented adverse events by their likelihood (frequency) and the body system affected (SOC). Serious adverse reactions are always presented distinctly to communicate the most critical risks identified during clinical trials or post-market monitoring. This standardized approach is used by government agencies to formally define the medicine’s risk profile and limitations for use.

Overdose and Emergency Response

The official regulatory profile for Tecon (Piroxicam) overdose focuses on documenting known acute manifestations and mandating immediate emergency response.

A suspected overdose may present with a spectrum of symptoms primarily affecting the gastrointestinal (GI) tract, such as nausea, vomiting, stomach pain, and diarrhea. Central Nervous System (CNS) effects, including drowsiness, severe headache, confusion, and agitation, are also documented. Overdose carries the risk of serious or life-threatening outcomes, including severe GI complications like bleeding and perforation, CNS depression leading to convulsions or coma, and acute renal failure.

Immediate medical attention is required upon any suspicion of overdose and must not be delayed. Regulatory authorities mandate immediate contact with emergency services or a poison control center.

Management is strictly symptomatic and supportive, as the official labeling confirms no specific antidote is available for Piroxicam toxicity. Supportive measures may include the administration of activated charcoal and continuous monitoring of vital signs (e.g., blood pressure and ECG) and hospital observation. Patients who are elderly are noted to be at a higher risk for serious GI adverse events, which are a key complication in NSAID toxicity.

Therapeutic Uses of Tecon

Tecon is commonly used to help with symptomatic relief by addressing the pain, swelling, and stiffness associated with various conditions driven by inflammatory or irritative states. The medication is applied in clinical settings that involve acute or unstable symptom patterns, where supportive relief is needed to ease the overall symptom load.

The medication is considered relevant for managing symptom clusters that may become intense or disruptive in conditions such as Osteoarthritis, Rheumatoid Arthritis, Ankylosing Spondylitis, and acute gouty arthritis. It is also commonly used when short-term symptomatic assistance is appropriate for specific painful episodes like primary dysmenorrhea.

“Tecon contributes to improved day-to-day comfort and assists with maintaining functional stability when symptoms are more noticeable.”

Managing Symptoms of Inflammatory Conditions

The medication is considered relevant for managing chronic discomfort, and may contribute to easing the overall symptom burden associated with long-term joint diseases. It is often used during phases when symptoms intensify and supportive relief is needed, supporting the patient during difficult episodes by easing distress.


Quick Fact: Relief for Inflammatory Pain

Tecon is commonly used to help with pain and stiffness when symptoms are related to underlying inflammation. The goal is to provide symptomatic relief for conditions that present with inflammatory or irritative processes.

Regulatory References

  1. NIH MedlinePlus overview on Piroxicam

Eligibility and Restrictions for Use

Official Eligibility Profile for Tecon (Piroxicam)

Regulatory agencies define strict population eligibility for Tecon based on age, pre-existing health conditions, and physiological status. This information is derived from official prescribing documents.


Category Official Regulatory Status
Populations Contraindicated Must not be used in patients with active or a history of GI ulceration, bleeding, or perforation. It is also prohibited for those with severe heart failure or a history of allergic reactions (e.g., asthma, urticaria) to aspirin or other NSAIDs, and for pain following CABG surgery.
Age-Related Rules Adults (18+ years) are the approved population. Pediatric use (under 18 years) has safety and effectiveness not been established. Use is avoided or requires extreme caution in the elderly, particularly those over 80 years of age.
Conditional/Restricted Use Caution is required for patients with uncontrolled hypertension, established cardiovascular disease, or hepatic/renal impairment. Use of Tecon is not recommended with other systemic NSAIDs.
Pregnancy/Lactation Contraindicated in the third trimester of pregnancy (from 30 weeks gestation). Use between 20 and 30 weeks is highly restricted and should be limited. Not recommended for use by women who are breastfeeding.

The regulatory profile clearly establishes non-eligibility for individuals with a high risk of GI or cardiovascular complications and prohibits use during late pregnancy. All other patient groups with certain health conditions, such as organ impairment or advanced age, require a cautious, conditional approach to use.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Tecon (Piroxicam) establishes specific constraints regarding co-administration with other medicines and substances. Certain combinations are formally contraindicated: co-administration with other Nonsteroidal Anti-inflammatory Drugs (NSAIDs), including COX-2 selective agents, is prohibited due to the additive risk of serious gastrointestinal events. Tecon is also contraindicated for the treatment of peri-operative pain related to Coronary Artery Bypass Graft (CABG) surgery.

Clinically significant pharmacodynamic interactions affect hemostasis and renal function. The co-administration of Tecon with Anticoagulants (e.g., Warfarin), SSRIs, and Oral Corticosteroids significantly increases the risk of bleeding and gastrointestinal ulceration. Additionally, Tecon may diminish the antihypertensive or natriuretic effect of medicines such as ACE Inhibitors, ARBs, Beta-Blockers, and Diuretics. This interaction carries a heightened risk of renal function deterioration in elderly, volume-depleted, or renally impaired patients.

Regarding pharmacokinetic interactions, Tecon may increase the serum concentration of co-administered drugs, specifically Lithium, Digoxin, and Methotrexate, which can pose toxicity risks. Tecon is primarily metabolized by the CYP2C9 enzyme, and individuals classified as poor metabolizers of this pathway may have higher systemic exposure to Piroxicam. Finally, regulatory documents state that alcohol consumption is a factor that increases the risk of serious gastrointestinal complications. Co-administration with food only results in a slight delay in the rate of absorption.

Mechanism of Action

Molecular Action: Non-selective Cyclooxygenase Inhibition

Tecon (Piroxicam) acts at the molecular level as a non-selective inhibitor of the Cyclooxygenase (COX) enzymes, specifically COX-1 and COX-2. This competitive interaction prevents the conversion of arachidonic acid into prostaglandins, which are chemical mediators involved in the propagation of inflammatory signals.


Cascade Effect: Modulation of Nociceptive and Thermoregulatory Signaling

The reduction in prostaglandin synthesis modifies two key physiological systems. Peripherally, lower levels of PGE2 dampen the chemical sensitization of nociceptors (pain-sensing nerves), resulting in the modulation of peripheral nociceptive signaling. Centrally, the inhibition of PGE2 production in the hypothalamus resets the elevated thermoregulatory set point. This dual action results in the combined physiological changes associated with the mechanism.


Mechanism Limitation: Focus on Mediator Synthesis

The drug's action is fundamentally modulatory, focusing on the chemical consequences of tissue injury at the level of prostaglandin synthesis. The non-selective inhibition inherently affects COX-1, which is linked to basal, homeostatic physiological functions, and does not influence structural repair or cellular regeneration pathways.

Dosage and Administration Information

How to Use Tecon

Tecon (Piroxicam) is officially administered via three routes: oral (capsule or tablet), intramuscular (IM) injection, and topical (gel) application, with the total daily dosage across all forms strictly limited to the maximum recommended amount.

Standard Dosing Regimen

For chronic maintenance use, such as managing long-term inflammatory conditions, the typical adult dose is 20 mg of the oral form, administered once daily. The medicine’s long half-life supports this once-daily frequency, though the total daily dose may be divided. For the initial treatment of acute episodes, the prescribing information allows for a loading dose of 40 mg daily for a limited course, such as four to six days for acute gout, before the dose must be reduced or discontinued. Intramuscular injection is typically reserved only for the initiation of these acute symptomatic periods before transitioning to the oral form.


Administration and Duration Principles

Oral capsules must be swallowed whole and are instructed to be taken with or immediately after food or with a full glass of water. This instruction is provided in the official labeling to address proper administration context. Treatment duration adheres to the principle of using the lowest effective dose for the shortest duration possible to achieve the desired outcome. Furthermore, the official protocol for chronic use requires a formal re-evaluation of the treatment’s necessity and benefit within 14 days of initiation.

Population Adjustments

Dose modifications are specified for certain patient groups. A reduced dosage and shorter duration of treatment should be considered for older adults. Similarly, lower doses and close monitoring are necessitated for patients with renal or hepatic impairment due to altered drug clearance. Pediatric dosing, where approved, is determined based on body weight.

Recent Clinical Evidence

Research evidence / Overview of Studies for Tecon

This section provides a summary of the available clinical research, focusing on the types of studies that have been conducted for Tecon (Piroxicam) and the patterns that findings describe, without offering clinical advice or making treatment claims.


Evidence for Symptomatic Relief in Osteoarthritis and Rheumatoid Arthritis

The research into Tecon for conditions like Osteoarthritis (OA) and Rheumatoid Arthritis (RA) includes Randomized Controlled Trials (RCTs) and meta-analyses. These trials generally explore how symptoms change over defined time intervals in adults diagnosed with these conditions. Piroxicam was evaluated in these studies against inactive treatments (placebo) or other Nonsteroidal Anti-inflammatory Drugs (NSAIDs).

The findings from these controlled trials and observational studies include patient-reported outcomes describing perceived discomfort, stiffness, and functional measures over the observation period. The research explored how symptoms evolved in the observed populations, with studies monitoring measurements of daily functioning or activity level. Studies focusing on episodes where symptoms become more noticeable contribute to the broader evidence landscape.

Studies Evaluating Change in Joint Pain and Functional Ability

The main trials for these chronic joint conditions monitored specific patient-reported outcomes describing perceived discomfort. Researchers used validated scales to assess the severity of pain, the duration of morning stiffness, and the patient's global assessment of their disease activity. For conditions like Osteoarthritis, the trials included outcomes reflecting daily functioning, such as walking ability or movement restriction. The research describes that these studies monitored outcomes related to episodic or acute changes, with follow-up periods in many controlled trials being limited to a few weeks or months.


Research Evidence for Acute Inflammatory Conditions

Tecon was studied for its use in managing acute, episodic symptom patterns in conditions like Ankylosing Spondylitis (AS) and acute Gouty Arthritis. The research for AS primarily involved comparative studies where Piroxicam was studied alongside other NSAIDs, with studies exploring changes in pain and stiffness.

Evidence for Acute Gout Management

Research on acute gout involved clinical trials focusing on rapid symptomatic changes during a flare-up. Studies monitored outcomes related to episodic or acute changes and measured symptom intensity shortly after treatment began. The studies reported measurements of symptom intensity or variability observed in the groups over the defined time interval. The monitoring period for symptom resolution was often brief—around a few days of observation.


Long-Term Research and Durability of Response

While many controlled comparative trials focus on short-term changes (typically 3 to 12 weeks), data from some long-term observational settings and extended-duration studies are available for chronic conditions. These longer studies have observed patient responses over periods up to one year or longer, contributing to the broader evidence landscape for long-term use.

However, long-term outcomes are not fully characterized by the same robust, controlled trial designs used for the initial short-term assessment. Research is ongoing, and the existing long-term evidence mainly describes observational patterns rather than providing the same certainty derived from extended, randomized follow-up.

Key Studies & References

  1. Piroxicam: MedlinePlus Drug Information
  2. Piroxicam - LiverTox - Clinical and Research Information on Drug-Induced Liver Injury (NIH)
  3. Efficacy and safety of piroxicam revisited: a global meta-analysis of randomised clinical trials (CRD Abstract)

Frequently Asked Questions (FAQ)

Common questions about Tecon (FAQ)


Q: Why do people sometimes say Tecon is different from older treatments for this condition?

Official information describes the drug as having an exceptionally long half-life in the body. This feature is a key differentiator from many other anti-inflammatory agents. Due to this long duration of action, the drug is typically administered only once daily to maintain stable concentrations.


Q: In general terms, when is the best time of day to take Tecon?

Because of the drug's long half-life, official documents advise taking it at the same time each day. This helps maintain consistent levels of the medicine in your body throughout the treatment period. The official guidance emphasizes that the timing be consistent, supporting stable levels regardless of morning or evening administration.


Q: What are the main differences between Tecon and a similar medicine often mentioned on forums?

Official information identifies the long half-life as a key difference when comparing it to some similar anti-inflammatory agents. This property allows for a simple once-daily administration schedule.


Q: Where can I find the full, official prescribing information (like the FDA label or SmPC)?

The full official labeling is published by government regulatory agencies such as the FDA (DailyMed) or the EMA (SmPC). These documents contain complete details about the drug's use, safety, and pharmacology. You may also request a copy of the official prescribing information through your pharmacy or healthcare provider.


Q: Why does the official leaflet list so many potential drug interactions?

Interactions are listed because the medicine can affect multiple important body systems, including how the blood clots (hemostasis) and how the kidneys filter substances. It also interacts with the CYP2C9 enzyme, which is involved in breaking down many other medicines.


Q: What is the maximum duration of use for Tecon discussed in research?

Regulatory documents emphasize that the drug should be used at the lowest effective dose for the shortest duration possible. While some observational research has followed patients for a year or longer, controlled clinical trials are often shorter. Regulatory guidance requires careful and regular re-evaluation for long-term use.


Q: How is the initial dosing of Tecon determined by prescribers?

The dose is determined based on the condition being treated, as outlined in the official prescribing information. For chronic conditions, the standard maintenance dose is typically used. However, a higher initial loading dose may be allowed for a very limited time to manage acute, sudden symptomatic periods.


Q: Can Tecon cure the underlying condition it treats?

Tecon belongs to the class of medicines intended for the symptomatic relief of pain and inflammation associated with conditions like osteoarthritis and rheumatoid arthritis. The official description confirms the medicine works to manage symptoms by reducing pain and inflammation, but it is not intended to cure the underlying disease process.


Q: Is it normal to feel a mild headache when first starting Tecon?

Headache is one of the possible adverse effects reported in the official safety documentation. This medicine can affect people differently. Official documentation advises communicating any unusual or persistent symptoms to a healthcare provider.


Q: How common are the severe side effects of Tecon?

Official safety information describes the potential for serious adverse events, including risks of gastrointestinal bleeding and cardiovascular thrombotic events (like heart attack or stroke). These are highlighted in regulatory documents to communicate critical risks that may occur with use.


Q: Are there any known long-term side effects from using Tecon for many years?

Official safety information notes that the potential for certain risks, such as serious gastrointestinal or cardiovascular events, may increase with the duration of use. Because of these concerns, regulatory guidance requires careful and regular re-evaluation for long-term use.


Q: Does taking Tecon affect a person's weight?

Official documents mention the possibility of fluid retention (edema) as a possible adverse effect. Edema involves retaining water, which can lead to changes in weight. Any unexpected or significant changes in weight should be communicated to a healthcare provider.


Q: Can Tecon cause skin sensitivity to sunlight?

Documentation for the topical (gel) form of the medicine describes the potential for skin to become more sensitive to sunlight than usual. Official documentation recommends protecting treated areas from strong or prolonged sun exposure.


Q: Is there a risk of physical or psychological dependence with Tecon?

Tecon is a Nonsteroidal Anti-inflammatory Drug (NSAID). Based on the official safety documentation for this class of medicine, there are no warnings regarding physical or psychological dependence listed in the product information.


Q: Are there any specific foods or drinks that should be avoided while taking Tecon?

Official guidance suggests that certain acidic foods or juices, particularly citrus juices, may affect how the drug is absorbed and are best avoided around the time of the dose. Limiting caffeine intake is also sometimes recommended due to the potential for additive side effects like nervousness.


Q: What happens if Tecon is taken along with a daily multivitamin?

Regulatory information for the drug does not typically list specific interactions with common multivitamins. Official safety documents advise communicating the use of all other medications, vitamins, and herbs to a healthcare provider to check for any potential conflicts.


Q: Does nicotine or smoking affect how Tecon works in the body?

Official warnings state that smoking is considered a risk factor that significantly increases the chance of serious gastrointestinal complications, including ulceration and bleeding, associated with this medicine.


Q: How long does it typically take to notice the effects of Tecon?

Due to the drug's long half-life, stable drug levels in the body are typically not achieved for 7 to 12 days. Because there is a progressive increase in concentration, the full therapeutic effect should not be assessed until after approximately two weeks of consistent use.


Q: What is the recommended approach if a person misses a dose of Tecon?

Official instructions advise that if a dose is missed, it should be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped entirely. Official instructions state that taking double or extra doses is not recommended.


Q: What should a patient expect during the first few weeks of using Tecon?

During the first few weeks, the full effect of the medicine may not be reached, as stable drug levels can take up to 7 to 12 days to develop. Patients should also be aware of possible common side effects reported during initial treatment, such as headache, dizziness, or indigestion.


Q: What kind of patient monitoring (like blood tests) is usually required while on Tecon?

Official documentation requires the monitoring of certain body functions, especially for high-risk patients. This monitoring may include checking blood pressure, renal (kidney) function, and hemoglobin/hematocrit levels due to the potential risk of bleeding.


Q: Is Tecon known to affect sleep patterns?

Official documentation lists drowsiness and sleepiness as possible adverse effects of the medicine. Due to these potential effects, official warnings advise caution when driving or operating machinery.


Q: Can I take Tecon if I am also using herbal supplements like St. John's Wort?

The official labeling advises that all healthcare providers be informed about the use of any herbs or dietary supplements. This advice is provided because some supplements may carry a risk of interactions, such as increasing the potential for bleeding complications.


Q: Does taking Tecon impact the ability to drive or operate machinery?

Official warnings are in place to ensure patient safety when driving or operating machinery. This is because the medicine may cause adverse effects such as dizziness, drowsiness, or blurred vision, which could affect alertness and reaction time.


Q: Are there different versions or brands of Tecon?

The active ingredient in Tecon, Piroxicam, is available under multiple names. This includes a brand name, Feldene®, and various generic versions that contain the same active substance.


Q: Does Tecon need to be taken consistently at the exact same time every day?

Yes, official guidance states that the medicine should be taken around the same time each day. This helps maintain a consistent level of the medicine in the body, which is important given its long half-life.


Q: Are there any known issues with Tecon when traveling across time zones?

Because the medicine is typically taken once daily at the same time, traveling across time zones may require adjusting the schedule to maintain the correct 24-hour interval between doses. Consulting a healthcare provider is recommended for guidance on managing the timing.


Q: What does the term 'Tecon-related adverse event' actually mean?

An adverse event is defined in official documentation as any undesirable experience observed in a patient during treatment. It is an observed negative outcome, whether or not it is believed to be caused by the medicine itself.


Q: What evidence exists about Tecon's effect on quality of life?

Clinical research has focused on patient-reported outcomes such as measurements of daily functioning, discomfort, and stiffness. Since the medicine's purpose is symptomatic relief, these measures contribute to the overall understanding of how the medicine may affect a patient's quality of life.


Q: Is it normal to feel a difference in appetite when starting Tecon?

Loss of appetite is one of the possible adverse effects listed in the official safety information for this medicine. Any changes in appetite or other new symptoms should be communicated to a healthcare provider.

How should Tecon be stored and disposed of?

The storage and disposal of Tecon (Piroxicam) must strictly follow the conditions detailed in the official regulatory labeling to preserve the product's quality and strength.

Storage Conditions

Requirement Official Regulatory Mandate
Temperature Range Store at controlled room temperature, generally 20 C to 25 C (68 F to 77 F). Excursions between 15 C and 30 C are permitted.
Protection Keep away from excessive heat, moisture, and direct light. The product must not be frozen.
Container Keep the medicine in its original container and ensure the container is tightly closed.

Child-Safety and Disposal

Requirement Official Regulatory Mandate
Child Safety Keep out of the reach and sight of children and pets.
Disposal Unused or expired medicine should be disposed of via an authorized drug take-back program. If unavailable, mix the medicine with an undesirable substance (e.g., used coffee grounds) and place the mixture in a sealed bag before throwing it in the household trash. Do not flush or allow the product to enter drains.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Tecon found in:

A-Z Index: